Cysteamine Bitartrate Crystallization Process

The patent applies parameter changes by systematically varying reaction conditions (temperature, solvent type, concentration, pH) to control the formation of specific crystalline forms (L1 and L2) with distinct X-ray diffraction patterns. By optimizing these parameters, the process achieves high purity (>98% HPLC) and stable crystalline forms while maintaining a relatively simple one-pot synthesis approach.

The patent utilizes phase transitions during the crystallization process to obtain stable crystalline forms. By controlling cooling rates, solvent evaporation, or supersaturation conditions, the process facilitates controlled phase changes from solution to solid crystalline state, ensuring formation of reproducible crystalline forms L1 and L2 with characteristic diffraction patterns.

The patent employs feedback mechanisms by monitoring reaction progress and crystallization characteristics through analytical methods (HPLC for purity, X-ray diffraction for crystalline form identification). This feedback allows real-time adjustment of process parameters to ensure consistent formation of stable polymorphic forms, achieving reliability while maintaining ease of manufacture through automated monitoring and control.

The patent applies preliminary action by pre-establishing optimized reaction conditions and crystallization protocols before actual production. This includes pre-determining optimal temperature ranges, solvent ratios, and addition rates based on preliminary experimental studies, thereby ensuring consistent and reliable formation of crystalline forms L1 and L2 in subsequent manufacturing operations.